Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Helitrons are enriched in lichenized fungi with long generation lengths and small distribution sizes.

G3 (Bethesda, Md.)·2026

Same author

GABA-mediated regulation of lipid metabolism: a conserved relation with diverse physiological significances.

Frontiers in physiology·2026

Same author

Distinct prion conformers from brain and peripheral tissues of gene-targeted mice produce convergent CWD strain properties.

PLoS pathogens·2026

Same author

Sexual dimorphism in the colonic microbiome and host's transcriptomics profiles of a murine model of multiple sclerosis.

Clinical immunology communications·2026

Same author

Farnesol, the farnesol pathway, and the immune-gut-brain axis.

Frontiers in pharmacology·2026

Same author

Impact of a GABA-Producing <i>Lactococcus lactis</i> on Microbiota and Mycobiota During CNS Inflammatory Demyelination.

FASEB bioAdvances·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2025

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Farnesol brain transcriptomics in CNS inflammatory demyelination.

William J Doyle¹, Dana Walters², Xutong Shi²

¹Department of Biological Sciences, Boise State University, Boise, ID 83725, USA.

Clinical Immunology (Orlando, Fla.)

|September 6, 2023

Summary

This summary is machine-generated.

Farnesol (FOL) reduces inflammation in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). This study reveals FOL

Keywords:

Brain EAE Farnesol Isoprenoids Transcriptomics

More Related Videos

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jul 17, 2025

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

Area of Science:

Neuroimmunology
Molecular Biology
Transcriptomics

Background:

Farnesol (FOL) demonstrates preventative effects against experimental autoimmune encephalomyelitis (EAE).
EAE serves as a widely used murine model for studying multiple sclerosis (MS).

Purpose of the Study:

To investigate the molecular mechanisms underlying FOL's therapeutic effects in EAE.
To analyze the brain's transcriptomic profile in EAE mice treated with FOL.

Main Methods:

Next-generation sequencing (RNA-seq) was employed to analyze whole brain transcriptomes.
Comparative analysis was performed between EAE mice treated with FOL and untreated EAE mice.

Main Results:

EAE induction led to increased immune response and cytokine signaling pathways, with decreased cellular stress proteins.
FOL treatment downregulated pro-inflammatory pathways, including those involved in misfolded protein response and MAPK signaling.
FOL attenuated the overall immune response in the EAE model.

Conclusions:

Farnesol exerts significant molecular effects within the brain during EAE.
The findings highlight potential therapeutic targets within the isoprenoid pathway for MS treatment.